Table 2. Effects of CypA SNPs C1604G and A1650G on disease progression in the Amsterdam cohort of MSM.

SNP	Endpoint	Number	Events	RH (95% C.I.)	p-value
C1604G	AIDS (CDC1987)	334	211	0.91 (0.63–1.31)	0.61
	AIDS (CDC1993)	333	235	0.84 (0.59–1.20)	0.34
	CD4<200 cells/µl	333	199	0.84 (0.57–1.23)	0.37
	RNA>104.5 copies/ml	331	232	1.02 (0.71–1.45)	0.92
A1650G	AIDS (CDC 1987)	334	211	0.97 (0.71–1.33)	0.87
	AIDS (CDC1993)	333	235	1.07 (0.80–1.43)	0.67
	CD4<200 cells/µl	333	199	0.98 (0.70–1.36)	0.89
	RNA>104.5 copies/ml	331	232	0.88 (0.65–1.20)	0.42

P-values were from Cox proportional hazard analysis.